Chemeq confirms details of $50m capital raising
Wednesday, 18 August, 2004
Chemeq (ASX: CMQ) has confirmed that its capital raising will include a placement of around AUD$10 million to institutions and sophisticated investors, as well as an underwritten rights offer of around $40 million to existing shareholders.
The placement is not likely to be completed until early next week, according to CEO Graham Melrose, and the rights issue will take another 3-4 weeks to complete. Shareholder approval is not required for the process.
Melrose said the placement price would be subject to a book building exercise, but would be likely to be in the region of $2.40-2.70.
The company is in voluntary suspension while it finalises the placement.
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
